This award funds projects developing or validating clinical outcomes and biomarkers to enrich ALS clinical trials. Research may focus on specific therapies, therapeutic classes, or ALS subtypes, and include digital health measures like wearable devices or imaging. Community collaboration with the ALS lived experience is a key component. Projects may optimize existing outcome measures or develop new ones across various biomarker categories.
Open to any type of entity with no explicit restrictions. Applicants must demonstrate how their research is informed by the ALS lived experience community.
